| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |